4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-020188
Chief Commercial Officer sold 3,457 shares at an average $4.11 ($14,210)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Marshak Richard Chief Commercial Officer | 2026-03-11 | Sale | −1,449 | $4.13 | $5,984 | 112,405 | D |
| Marshak Richard Chief Commercial Officer | 2026-03-12 | Sale | −1,589 | $4.09 | $6,499 | 110,816 | D |
| Marshak Richard Chief Commercial Officer | 2026-03-16 | Sale | −419 | $4.12 | $1,726 | 110,397 | D |
| Open-market sales · 3,457 sh · avg $4.11 · $14,210 | |||||||
Loading xslF345X06/wk-form4_1774038338.xml…